Molecular basis of mEAK7-mediated human V-ATPase regulation.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 35672408.
- Also identified by DOI 10.1038/s41467-022-30899-z and PMC identifier 9174246.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
The activity of V-ATPase is well-known to be regulated by reversible dissociation of its V<sub>1</sub> and V<sub>o</sub> domains in response to growth factor stimulation, nutrient sensing, and cellular differentiation. The molecular basis of its regulation by an endogenous modulator without affecting V-ATPase assembly remains unclear. Here, we discover that a lysosome-anchored protein termed (mammalian Enhancer-of-Akt-1-7 (mEAK7)) binds to intact V-ATPase. We determine cryo-EM structure of human mEAK7 in complex with human V-ATPase in native lipid-containing nanodiscs. The structure reveals that the TLDc domain of mEAK7 engages with subunits A, B, and E, while its C-terminal domain binds to subunit D, presumably blocking V<sub>1</sub>-V<sub>o</sub> torque transmission. Our functional studies suggest that mEAK7, which may act as a V-ATPase inhibitor, does not affect the activity of V-ATPase in vitro. However, overexpression of mEAK7 in HCT116 cells that stably express subunit a4 of V-ATPase represses the phosphorylation of ribosomal protein S6. Thus, this finding suggests that mEAK7 potentially links mTOR signaling with V-ATPase activity.
Medical subject headings
- Vacuolar Proton-Translocating ATPases